Pfizer (PFE)

Income Tax Expense

-$164.00M

TTM · Period ending: · USD

PFE logo

PFE Income Tax Expense

Latest reported-$164.00M
PFE TTM Income Tax ($0.00 → -$164.00M)
High-resolution chart · PNG

PFE income tax expense history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Pfizer Income Tax Expense — Trailing twelve months (TTM) (USD)
Period endingIncome Tax Expense (USD)
2,179,000,000
2,102,000,000
1,866,000,000
1,714,000,000
1,558,000,000
1,343,000,000
1,244,000,000
897,000,000
818,000,000
791,000,000
727,000,000
944,000,000
971,000,000
875,000,000
865,000,000
873,000,000
892,000,000
895,000,000
869,000,000
812,600,000
787,400,000
766,300,000
741,500,000
715,600,000
653,700,000
607,700,000
558,500,000
516,500,000
256,100,000
234,800,000
191,300,000
195,700,000
415,800,000
450,300,000
438,600,000
296,600,000
280,500,000
222,900,000
218,400,000
311,800,000
313,700,000
303,600,000
297,900,000
240,400,000
150,000,000
93,600,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.